112 related articles for article (PubMed ID: 10380831)
1. Intravesical administration of radiolabelled tumour-associated monoclonal antibody in bladder cancer.
Syrigos KN; Khawaja M; Krausz T; Williams G; Epenetos AA
Acta Oncol; 1999; 38(3):379-82. PubMed ID: 10380831
[TBL] [Abstract][Full Text] [Related]
2. Immunolocalization of transitional cell carcinoma of the bladder with intravesically administered technetium-99m labelled HMFG1 monoclonal antibody.
Malamitsi J; Zorzos J; Varvarigou AD; Archimandritis S; Dassiou C; Skarlos DV; Dimitriou P; Likourinas M; Zizi A; Proukakis C
Eur J Nucl Med; 1995 Jan; 22(1):25-31. PubMed ID: 7698151
[TBL] [Abstract][Full Text] [Related]
3. Intravesical administration of indium-111-labelled HMFG2 monoclonal antibody in superficial bladder carcinomas.
Bamias A; Bowles MJ; Krausz T; Williams G; Epenetos AA
Int J Cancer; 1993 Jul; 54(6):899-903. PubMed ID: 8335396
[TBL] [Abstract][Full Text] [Related]
4. Targeting superficial bladder cancer by the intravesical administration of copper-67-labeled anti-MUC1 mucin monoclonal antibody C595.
Hughes OD; Bishop MC; Perkins AC; Wastie ML; Denton G; Price MR; Frier M; Denley H; Rutherford R; Schubiger PA
J Clin Oncol; 2000 Jan; 18(2):363-70. PubMed ID: 10637251
[TBL] [Abstract][Full Text] [Related]
5. Preclinical studies of monoclonal antibodies for intravesical radioimmunotherapy of human bladder cancer.
Russell PJ; Davis K; Kingsley E; Humphreys J; Hanley J; O'Grady H; Pearce N
Cell Biophys; 1994; 24-25():155-61. PubMed ID: 7736520
[TBL] [Abstract][Full Text] [Related]
6. Immunotargeting of urothelial cell carcinoma with intravesically administered Tc-99m labeled HMFG1 monoclonal antibody.
Malamitsi J; Zorzos J; Varvarigou AD; Archimandritis S; Dassiou C; Sivolapenko G; Skarlos DV; Serefoglou A; Lykourinas M; Proukakis C
Cell Biophys; 1994; 24-25():75-81. PubMed ID: 7736542
[TBL] [Abstract][Full Text] [Related]
7. Epithelial mucin expression in bladder cancer: correlation with pathological and clinical parameters.
Syrigos KN; Deonarain DM; Karayiannakis A; Waxman J; Krausz T; Pignatelli M
Urol Res; 2000 Aug; 28(4):241-5. PubMed ID: 11011962
[TBL] [Abstract][Full Text] [Related]
8. Preclinical evaluation of copper-67 labelled anti-MUC1 mucin antibody C595 for therapeutic use in bladder cancer.
Hughes OD; Bishop MC; Perkins AC; Frier M; Price MR; Denton G; Smith A; Rutherford R; Schubiger PA
Eur J Nucl Med; 1997 Apr; 24(4):439-43. PubMed ID: 9096097
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies for intravesical radioimmunotherapy of human bladder cancer.
Russell PJ; Plomley J; Shon IH; O'Grady H; Pearce N
Cell Biophys; 1993; 22(1-3):27-47. PubMed ID: 7889541
[TBL] [Abstract][Full Text] [Related]
10. Production and characterization of 188Re-C595 antibody for radioimmunotherapy of transitional cell bladder cancer.
Murray A; Simms MS; Scholfield DP; Vincent RM; Denton G; Bishop MC; Price MR; Perkins AC
J Nucl Med; 2001 May; 42(5):726-32. PubMed ID: 11337567
[TBL] [Abstract][Full Text] [Related]
11. Targeting of bladder cancer with monoclonal antibody NCRC48--a possible approach for intravesical therapy.
Kunkler RB; Bishop MC; Green DJ; Pimm MV; Price MR; Frier M
Br J Urol; 1995 Jul; 76(1):81-6. PubMed ID: 7648066
[TBL] [Abstract][Full Text] [Related]
12. Intravesical administration of radiolabeled antitumor monoclonal antibody in bladder carcinoma.
Bamias A; Keane P; Krausz T; Williams G; Epenetos AA
Cancer Res; 1991 Jan; 51(2):724-8. PubMed ID: 1985790
[TBL] [Abstract][Full Text] [Related]
13. Intravesical alpha-radioimmunotherapy with 213Bi-anti-EGFR-mAb defeats human bladder carcinoma in xenografted nude mice.
Pfost B; Seidl C; Autenrieth M; Saur D; Bruchertseifer F; Morgenstern A; Schwaiger M; Senekowitsch-Schmidtke R
J Nucl Med; 2009 Oct; 50(10):1700-8. PubMed ID: 19793735
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics, biodistribution, and dosimetry of specific and control radiolabeled monoclonal antibodies in patients with primary head and neck squamous cell carcinoma.
Maraveyas A; Stafford N; Rowlinson-Busza G; Stewart JS; Epenetos AA
Cancer Res; 1995 Mar; 55(5):1060-9. PubMed ID: 7866989
[TBL] [Abstract][Full Text] [Related]
15. Intravesical administration of tumor-associated monoclonal antibody AUA1 in transitional cell carcinoma of the bladder: a study of biodistribution.
Zorzos J; Skarlos DV; Epenetos AA; Pectasides D; Koutsioumba P; Elemenoglou J; Bakiras A; Likourinas M; Dimopoulos K
Urol Res; 1993; 21(6):435-8. PubMed ID: 8171767
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical and immunocytochemical study of bladder carcinomas using the epithelium-specific, tumour-associated monoclonal antibodies HMFG1 and AUA1.
Anagnostaki E; Skarlos D; Tamvakis N; Psaropoulou P; Blana E; Bamias A; Legaki S; Aravantinos G; Deliveliotis C; Dimopoulos K
Br J Cancer Suppl; 1990 Jul; 10():52-6. PubMed ID: 2200496
[TBL] [Abstract][Full Text] [Related]
17. Growth and metastasis of human bladder cancer xenografts in the bladder of nude rats. A model for intravesical radioimmunotherapy.
Russell PJ; Ho Shon I; Boniface GR; Izard ME; Philips J; Raghavan D; Walker KZ
Urol Res; 1991; 19(4):207-13. PubMed ID: 1926654
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody Po66 uptake by human lung tumours implanted in nude mice: effect of co-administration with doxorubicin.
Desrues B; Léna H; Brichory F; Ramée MP; Toujas L; Delaval P; Dazord L
Br J Cancer; 1995 Nov; 72(5):1076-82. PubMed ID: 7577450
[TBL] [Abstract][Full Text] [Related]
19. Fractionated intravesical radioimmunotherapy with (213)Bi-anti-EGFR-MAb is effective without toxic side-effects in a nude mouse model of advanced human bladder carcinoma.
Fazel J; Rötzer S; Seidl C; Feuerecker B; Autenrieth M; Weirich G; Bruchertseifer F; Morgenstern A; Senekowitsch-Schmidtke R
Cancer Biol Ther; 2015; 16(10):1526-34. PubMed ID: 26177233
[TBL] [Abstract][Full Text] [Related]
20. Kinetics, quantitative analysis and radioimmunolocalization using indium-111-HMFG1 monoclonal antibody in patients with breast cancer.
Kalofonos HP; Sackier JM; Hatzistylianou M; Pervez S; Taylor-Papadimitriou J; Waxman JH; Lavender JP; Wood C; Epenetos AA
Br J Cancer; 1989 Jun; 59(6):939-42. PubMed ID: 2736231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
